Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28025837 | 0.93 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL19624056 | 0.93 | TSHR (0.60) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL3902375 | 0.92 | TSHR (0.47) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL11743891 | 0.91 | TSHR (0.49) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL21381448 | 0.91 | TSHR (0.49) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL2037179 | 0.91 | TSHR (0.49) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL10584690 | 0.91 | TSHR (0.49) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL10718051 | 0.91 | TSHR (0.49) | TSHRALDH1A1CYP3A4HPGDTHRB | |
| SCHEMBL51558 | 0.91 | TSHR (0.56) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16359346 | 0.88 | TSHR (0.38) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085135-A1 | CLEAVABLE FREE-RADICAL CURABLE COMPOSITION | ALLNEX BELGIUM S.A. (BE) | 2026-03-26 | — | — | US | disclosed |
| EP-4584305-A1 | CLEAVABLE FREE-RADICAL CURABLE COMPOSITION | Allnex Belgium, S.A. (BE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4448613-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKERS | 3M Innovative Properties Company (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024052491-A1 | CLEAVABLE FREE-RADICAL CURABLE COMPOSITION | ALLNEX BELGIUM, S.A. (BE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023111715-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-22 | — | — | WO | disclosed |
| EP-3134444-B1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-01-26 | — | — | EP | disclosed |
| EP-3134444-B1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-01-26 | — | — | EP | disclosed |
| US-10351649-B2 | Compositions comprising cleavable crosslinker and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-07-16 | — | — | US | disclosed |
| US-20180320025-A1 | ADHESIVE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2018-11-08 | — | — | US | disclosed |
| US-9994510-B2 | Anaerobic curable compositions containing blocked (meth)acrylic acid compounds | Henkel IP & Holding GmbH (DE) | 2018-06-12 | — | — | US | disclosed |
| US-20170298163-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2017-10-19 | — | — | US | disclosed |
| US-9732173-B2 | Compositions comprising cleavable crosslinker and methods | 3M INNOVATIVE PROPERTIES CO. (US) | 2017-08-15 | — | — | US | disclosed |
| US-9732173-B2 | Compositions comprising cleavable crosslinker and methods | 3M INNOVATIVE PROPERTIES CO. (US) | 2017-08-15 | — | — | US | disclosed |
| US-9732173-B2 | Compositions comprising cleavable crosslinker and methods | 3M INNOVATIVE PROPERTIES CO. (US) | 2017-08-15 | — | — | US | disclosed |
| US-20170066863-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-03-09 | — | — | US | disclosed |
| US-20170066863-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-03-09 | — | — | US | disclosed |
| US-20170044088-A1 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLIC ACID COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044088-A1 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLIC ACID COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2017-02-16 | — | — | US | disclosed |
| WO-2015168630-A1 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLIC ACID COMPOUNDS | Henkel IP & Holding GmbH (DE) | 2015-11-05 | — | — | WO | disclosed |
| WO-2015164087-A1 | COMPOSITIONS COMPRISING CLEAVABLE CROSSLINKER AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085135-A1 | CLEAVABLE FREE-RADICAL CURABLE COMPOSITION | ESD, COL2A1, CBR1 | TSHR 1419/4885ALDH1A1 917/4885CYP3A4 2893/4885 |
| US-20170044088-A1 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLIC ACID COMPOUNDS | AHCY, MMAB, MAT2B | TSHR 4853/4885ALDH1A1 277/4885CYP3A4 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.